News Releases

May 2, 2002

DaVita Announces Development Concerning the Company’s Florida Laboratory

Apr 29, 2002

Amgen Raises EPOGEN Pricing

Apr 26, 2002

DaVita Announces Closing of Note Tender Offer

Apr 23, 2002

DaVita Revises Purchase Price in Tender Offer and Consent Solicitation for Its 9.25% Senior Subordinated Notes Due 2011

Apr 19, 2002

DaVita Revises Tender Offers and Announces Satisfaction of Financing Condition